drugset / Trial / NCT01678924
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a safety and efficacy study of AGN-214868 in patients with postherpetic neuralgia (PHN).
Timeline
- Start
- 2013-01
- Primary completion
- 2015-05
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SENREBOTASE | Protein / enzyme biologic | — | Other |